Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Andrea Tan is an analyst at Goldman Sachs. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/07/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/01/2024 | SGMT | Buy Now | Sagimet Biosciences | $3.11 | 92.93% | $23 → $6 | Maintains | Neutral | Get Alert |
| 06/05/2024 | ARWR | Buy Now | Arrowhead Pharma | $25.57 | 21.24% | → $31 | Initiates | → Neutral | Get Alert |
| 06/05/2024 | RLMD | Buy Now | Relmada Therapeutics | $3.00 | -33.33% | $3 → $2 | Downgrade | Neutral → Sell | Get Alert |
| 05/29/2024 | INSM | Buy Now | Insmed | $70.05 | 5.64% | $49 → $74 | Maintains | Buy | Get Alert |
| 05/16/2024 | SGMT | Buy Now | Sagimet Biosciences | $3.11 | 639.55% | $27 → $23 | Maintains | Buy | Get Alert |
| 05/15/2024 | INSM | Buy Now | Insmed | $70.05 | -30.05% | $40 → $49 | Maintains | Buy | Get Alert |
| 03/26/2024 | SGMT | Buy Now | Sagimet Biosciences | $3.11 | 768.17% | $37 → $27 | Maintains | Buy | Get Alert |
| 02/29/2024 | IOVA | Buy Now | Iovance Biotherapeutics | $7.22 | 190.86% | $19 → $21 | Maintains | Buy | Get Alert |
| 02/29/2024 | TARS | Buy Now | Tarsus Pharmaceuticals | $28.30 | 6.01% | $19 → $30 | Maintains | Neutral | Get Alert |
| 02/27/2024 | DAWN | Buy Now | Day One Biopharmaceutical | $14.80 | 197.3% | $50 → $44 | Maintains | Buy | Get Alert |
| 02/21/2024 | IOVA | Buy Now | Iovance Biotherapeutics | $7.22 | 163.16% | $13 → $19 | Maintains | Buy | Get Alert |
| 02/20/2024 | IOVA | Buy Now | Iovance Biotherapeutics | $7.22 | 163.16% | $13 → $19 | Maintains | Buy | Get Alert |
| 01/23/2024 | SGMT | Buy Now | Sagimet Biosciences | $3.11 | 1089.71% | $30 → $37 | Maintains | Buy | Get Alert |
| 12/11/2023 | KOD | Buy Now | Kodiak Sciences | $2.46 | -18.7% | → $2 | Reinstates | → Sell | Get Alert |
| 11/20/2023 | IMGN | Buy Now | Immunogen | — | — | → $17 | Initiates | → Neutral | Get Alert |
| 11/20/2023 | KRYS | Buy Now | Krystal Biotech | $191.29 | -16.36% | → $160 | Initiates | → Buy | Get Alert |
| 11/20/2023 | IOVA | Buy Now | Iovance Biotherapeutics | $7.22 | 66.2% | → $12 | Initiates | → Buy | Get Alert |
| 11/20/2023 | TARS | Buy Now | Tarsus Pharmaceuticals | $28.30 | -32.86% | → $19 | Initiates | → Neutral | Get Alert |
| 08/08/2023 | DAWN | Buy Now | Day One Biopharmaceutical | $14.80 | 264.86% | $63 → $54 | Maintains | Buy | Get Alert |
| 08/08/2023 | SGMT | Buy Now | Sagimet Biosciences | $3.11 | 961.09% | → $33 | Initiates | → Buy | Get Alert |
| 08/04/2023 | ABCL | Buy Now | AbCellera Biologics | $2.78 | 763.31% | $27 → $24 | Maintains | Buy | Get Alert |
| 01/09/2023 | INSM | Buy Now | Insmed | $70.05 | -44.33% | $44 → $39 | Maintains | Buy | Get Alert |
| 01/09/2023 | FATE | Buy Now | Fate Therapeutics | $3.10 | 29.03% | $10 → $4 | Maintains | Sell | Get Alert |
| 01/09/2023 | DAWN | Buy Now | Day One Biopharmaceutical | $14.80 | 318.92% | $45 → $62 | Maintains | Buy | Get Alert |
| 12/20/2022 | MDGL | Buy Now | Madrigal Pharmaceuticals | $290.74 | 28.98% | $178 → $375 | Maintains | Buy | Get Alert |
| 12/15/2022 | ABCL | Buy Now | AbCellera Biologics | $2.78 | 979.14% | → $30 | Initiates | → Buy | Get Alert |
| 12/15/2022 | VERV | Buy Now | Verve Therapeutics | $5.67 | 129.28% | → $13 | Initiates | → Sell | Get Alert |
| 12/15/2022 | FATE | Buy Now | Fate Therapeutics | $3.10 | 222.58% | → $10 | Initiates | → Sell | Get Alert |
| 12/05/2022 | DAWN | Buy Now | Day One Biopharmaceutical | $14.80 | 204.05% | → $45 | Initiates | → Buy | Get Alert |
| 11/07/2022 | CDAK | Buy Now | Codiak BioSciences | — | — | $2 → $1.4 | Maintains | Neutral | Get Alert |
| 10/14/2022 | RLMD | Buy Now | Relmada Therapeutics | $3.00 | 166.67% | → $8 | Downgrade | Buy → Neutral | Get Alert |
| 09/23/2022 | RLMD | Buy Now | Relmada Therapeutics | $3.00 | 2600% | $49 → $81 | Maintains | Buy | Get Alert |
| 09/01/2022 | CDAK | Buy Now | Codiak BioSciences | — | — | $6 → $2 | Downgrade | Buy → Neutral | Get Alert |
| 05/24/2022 | VOR | Buy Now | Vor Biopharma | $0.93 | 332.39% | $6 → $4 | Maintains | Neutral | Get Alert |
| 05/24/2022 | INSM | Buy Now | Insmed | $70.05 | -31.48% | $56 → $48 | Maintains | Buy | Get Alert |
| 05/24/2022 | CDAK | Buy Now | Codiak BioSciences | — | — | $18 → $8 | Maintains | Buy | Get Alert |
| 04/27/2022 | VOR | Buy Now | Vor Biopharma | $0.93 | 548.58% | → $6 | Initiates | → Neutral | Get Alert |
| 04/27/2022 | INSM | Buy Now | Insmed | $70.05 | -20.06% | → $56 | Initiates | → Buy | Get Alert |
| 02/11/2022 | CDAK | Buy Now | Codiak BioSciences | — | — | → $19 | Initiates | → Buy | Get Alert |
